AbbVie’s migraine drug cleared for migraine attacks on NHS

Pharmaphorum

AbbVie's Aquipta can now be commissioned by the NHS in England and Wales as an acute treatment for migraine, after a NICE decision.

pharminent June 10, 2026 (Last updated: June 10, 2026)

Pharmaphorum

AbbVie’s Aquipta can now be commissioned by the NHS in England and Wales as an acute treatment for migraine, after a NICE decision.

Related Stories